Gypto Pharma nears agreement with 2 global firms for local drug production in H1 2025

Updated 12/2/2024 7:41:00 AM
Gypto Pharma nears agreement with 2 global firms for local drug production in H1 2025

Arab Finance: The Egyptian medicine city Gypto Pharma is in advanced negotiations to finalize agreements with two international firms in the first half (H1) of 2025, the city’s Chairman Amr Mamdouh told Asharq Business.

The two companies are expected to locally manufacture their products in Gypto Pharma City.

Both companies specialize in vaccine production and biological treatments for diabetes.

Related News